NICE recommends Bayer drug for severe short-sightedness
Eylea should be funded in mCNV, says NICE
X
NICE recommends Bayer drug for severe short-sightedness
https://pharmaphorum.com/news/nice-recommends-bayer-myopic-chorodial-neovascularisation/
Eylea should be funded in mCNV, says NICE